125 related articles for article (PubMed ID: 5068347)
1. [Kinin liberation by xantinol nicotinate?].
Seidel G; Wentz U
Arzneimittelforschung; 1972 Jun; 22(6):1012-3. PubMed ID: 5068347
[No Abstract] [Full Text] [Related]
2. Fibrinogen turnover during the treatment with xantinol nicotinate.
Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
[No Abstract] [Full Text] [Related]
3. [Influence of xantinol nicotinate on blood sugar level and free fatty acids in rats].
Brenner G
Arzneimittelforschung; 1971 Aug; 21(8):1179-83. PubMed ID: 5110015
[No Abstract] [Full Text] [Related]
4. Central hemodynamic responses to xantimol-nicotinate.
Blümchen G; Landry F; Schlosser V
Arzneimittelforschung; 1970 Aug; 20(8):1067-9. PubMed ID: 5536503
[No Abstract] [Full Text] [Related]
5. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
Bouvier CA; Berthoud S
Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
[No Abstract] [Full Text] [Related]
6. [Action of Sadamin, Polfa].
Lukjan H; Bielawiec M; Bogdanikowa B; Kiersnowska B; Korfel B; Dowzyk W
Pol Tyg Lek; 1972 May; 27(20):739-40. PubMed ID: 5029663
[No Abstract] [Full Text] [Related]
7. [Research on the fibrinolytic effects developed in vivo from 7-(2-[pyrid(3)yl-methylamino]ethyl) theophylline nicotinate. Preliminary note].
Preliminare N
Clin Ter; 1974 Nov; 71(4):321-33. PubMed ID: 4459005
[No Abstract] [Full Text] [Related]
8. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases].
Czestochowska E
Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036
[No Abstract] [Full Text] [Related]
9. [The influence of xantinol nicotinate on vascularisation and formation of vascular collaterals in extremity arteries in the animal experiment].
Schmitt G; Daake H
Arzneimittelforschung; 1971 Apr; 21(4):446-9. PubMed ID: 5108138
[No Abstract] [Full Text] [Related]
10. [Carbohydrate balance in the perfused isolated dog pancreas under the influence of xantinol-nicotinate].
Husemann B; Beer H
Arzneimittelforschung; 1974 Jan; 24(1):54-7. PubMed ID: 4406111
[No Abstract] [Full Text] [Related]
11. [Blood circulation increase in various organs following xantinol-nicotinate treatment in the acute animal experiment].
Winter R; Schmitt G; Knoche H
Arzneimittelforschung; 1973 May; 23(5):652-3. PubMed ID: 4740205
[No Abstract] [Full Text] [Related]
12. [Effect of xanthinol nicotinate on the isolated perfused lungs].
Husemann B
Arzneimittelforschung; 1970 Aug; 20(8):1070-1. PubMed ID: 5536505
[No Abstract] [Full Text] [Related]
13. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
Blasi A; Licciardello M
Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
[No Abstract] [Full Text] [Related]
14. [Cerebral circulation during hyperbaric oxygenation. Effects of 3-(methyl-hydroxyethylamino)-2-hydroxypropyl theophylline nicotinate. Preliminary note].
Albano G; Scaglione GC; Burruano G
Boll Soc Ital Biol Sper; 1970 Mar; 46(5):269-72. PubMed ID: 5457925
[No Abstract] [Full Text] [Related]
15. [Study of the pharmacodynamic effects of 3-(methyl-oxyethylamino)-2-oxypropyl-theophilline nicotinate on systemic arterial circulation].
De Gregorio G; Buda A; Fidecaro A
Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1721-5. PubMed ID: 5877915
[No Abstract] [Full Text] [Related]
16. [Clinical and experimental studies on the reduction of the duration of hexobarbitone anaesthesia by xantinol nicotinate].
Willmen HR; Loers FJ; Kalff G
Anaesthesist; 1973 Jan; 22(1):26-30. PubMed ID: 4692611
[No Abstract] [Full Text] [Related]
17. [Changes in fibrinolysis after administration of theophylline nicotinate].
Locatelli R; Centonza D; Bregani P; Esposito R
Haematologica; 1967; 52(2):132-42. PubMed ID: 4976133
[No Abstract] [Full Text] [Related]
18. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions].
Ipbüker A; Bayer H
Turk Tip Cemiy Mecm; 1969 Apr; 35(4):236-46. PubMed ID: 5810400
[No Abstract] [Full Text] [Related]
19. [Hemodynamics of the isolated kidney under the effect of xanthinol nicotinate].
Husemann B
Arzneimittelforschung; 1970 Aug; 20(8):1069-70. PubMed ID: 5536504
[No Abstract] [Full Text] [Related]
20. [Influence of xanthinol nicotinate on platelet agglutination test].
Steger W
Med Welt; 1973 Feb; 24(8):301-2. PubMed ID: 4688216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
